首页 | 本学科首页   官方微博 | 高级检索  
检索        

血清前白蛋白在肝细胞癌患者肝切除术后复发风险评估中的应用
引用本文:于里涵,谢峰,郑涛,付军,阎龙,杨甲梅.血清前白蛋白在肝细胞癌患者肝切除术后复发风险评估中的应用[J].吉林大学学报(医学版),2015,41(3):631-635.
作者姓名:于里涵  谢峰  郑涛  付军  阎龙  杨甲梅
作者单位:第二军医大学附属东方肝胆外科医院特需治疗一科, 上海 200438
基金项目:中国肝炎防治基金会基金资助课题(CFHPC20132193);CSCO基金资助课题(Y-B2011-006);第二军医大学2014年博士创新基金资助课题([2014]234号)
摘    要:目的:分析影响肝细胞癌(HCC)患者手术后复发的危险因素,评价血清前白蛋白(PA)在预测SHCC患者术后复发中的价值。方法:选取术后病理证明为HCC,且肿瘤单发、肿瘤直径≤5 cm、无血管癌栓的143例患者资料,并进行随访。以患者术后并发症发生情况分为无并发症组和并发症组,分析相关因素及实验室指标与术后并发症的关系,采用Kaplan-Meier生存曲线分析各因素对肿瘤复发的影响。结果:与无并发症组比较,术后出现并发症组患者PA下降率较高(P<0.05),其他指标比较无明显差异(P > 0.05)。143例患者总体复发率为44.7%,1、2和3年累积复发率为29%、39%和49%,总体中位无瘤生存期(DFS)43个月。HBV-DNA<103IU·mL-1和HBV-DNA≥103IU·mL-1患者1、2、3年无瘤生存率分别为85%、77%、67%和67%、52%、47%;PA下降<43%和PA下降≥43%的患者1、2、3年无瘤生存率分别为91%、81%、64%和66%、55%、47%。结论:HBV-DNA水平和肝切除术后PA下降率是HCC患者术后复发的危险因素。在危险因素存在的条件下,HCC患者复发时间差异明显。

关 键 词:肝肿瘤  前白蛋白  预后  乙型肝炎病毒  
收稿时间:2015-01-11

Application of serum prealbumin in evaluation on recurrence risk of patients with hepatocellular carcinoma after hepatectomy
YU Lihan;XIE Feng;ZHENG Tao;FU Jun;YAN Long;YANG Jiamei.Application of serum prealbumin in evaluation on recurrence risk of patients with hepatocellular carcinoma after hepatectomy[J].Journal of Jilin University: Med Ed,2015,41(3):631-635.
Authors:YU Lihan;XIE Feng;ZHENG Tao;FU Jun;YAN Long;YANG Jiamei
Institution:First Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
Abstract:Objective To analyze the risk factors associated with the recurrence in the patients with hepatocellular carcinoma (HCC), and to evaluate the value of serum prealbumin (PA) in predicting the recurrence in the patients with HCC after operation. Methods A retrospective study of the 143 patients, diagnosed by pathology with HCC after hepatectomy (solitary, tumor size≤5 cm and no metastases or major vascular invasion), was performed and the patients were divided into non-complication group and complication group by the occurrence of postoperative complication.The differences that related to tumor recurrence in two groups were evaluated using Kaplan-Meier curves. Results The patients with postoperative complications showed a higher descend rang of PA (P<0.05).The overall median disease free survival(DFS) and the rate of recurrence of 143 patients were 43 months and 44.7%, respectively. The 1-, 2-, 3- year recurrence rates of the patients after hepatectomy were 29%, 39% and 49%, respectively.The postoperative DFS rates of 1-, 2-, 3- year were 67%, 52%, and 47%, respectively, in the patients with HBV-DNA<103IU·mL-1, while they was 67%, 52%, and 47% in the patients with HBV-DNA≥103IU·mL-1.The postoperative DFS rate of 1-, 2-, 3- year were 91%, 81%, 64% respectively in the patients with PA decline <43%, while they were 66%, 55%, and 47% in the patients with decline PA≥43%. Conclusion The HBV-DNA level and the decline of postoperative PA are the risk factors of recurrence HCC of after hepatectomy.The recurrent time of the patients with HCC varies with the risk factors.
Keywords:liver neoplasms  prealbumin  prognosis  hepatitis B virus
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号